For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240612:nRSL2130Sa&default-theme=true
RNS Number : 2130S Plant Health Care PLC 12 June 2024
12 June 2024
Plant Health Care plc
("Plant Health Care" or the "Company")
Notice of General Meeting
Plant Health Care® (AIM.PHC.L), a leading provider of peptides used by
growers to improve crop production and quality within global agriculture
markets, announces that a Notice convening a General Meeting of Shareholders
(the "GM") has been mailed to shareholders and available on the Company's
website at www.planthealthcare.com.
The GM is to be held at the offices of Cavendish Capital Markets Limited, One
Bartholomew Close, London, EC1A 7BL on 28 June 2024 at 9:30 a.m., immediately
prior to the Company's Annual General Meeting, and is being convened for
technical purposes to ensure that the directors are re-elected as required in
accordance with the Company's Articles of Association.
For further information, please contact:
Plant Health Care plc
Jeff Tweedy, CEO
Tel: +1 919 926 1600
Cavendish Capital Markets Limited - Nomad & Broker Tel: +44 (0) 131 220 9771
Neil McDonald / Pete Lynch
About Plant Health Care
Plant Health Care offers products to improve the health, vigour and yield of
major field crops such as corn, soybeans, sugarcane, potatoes, rice, and
wheat, as well as specialty crops such as fruits and vegetables. We operate
globally through subsidiaries, distributors, and supply agreements with major
industry partners. Our innovative, patent-protected biological products help
growers to protect their crops from stress and diseases, and to produce higher
quality fruit and vegetables, with a favourable environmental profile.
Find out more at www.planthealthcare.com (http://www.planthealthcare.com/)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOGQKBBBABKDKAD